Philip Herman
Corporate Officer/Principal presso REPARE THERAPEUTICS INC.
Patrimonio netto: 18 482 $ in data 31/03/2024
Profilo
Philip Karl Herman is currently the Executive VP-Commercial & New Product Development at Repare Therapeutics, Inc. He previously worked as the Marketing Director at Vanda Pharmaceuticals, Inc. and as the Vice President, Head-Commercial & Marketing at Dyax Corp.
From 2018 to 2021, he served as the Chief Commercial Officer & Senior Vice President at Y-mAbs Therapeutics, Inc. Mr. Herman holds an MBA degree from Kellogg School of Management and an undergraduate degree from Baldwin Wallace University School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
REPARE THERAPEUTICS INC.
0.01% | 01/04/2024 | 3 924 ( 0.01% ) | 18 482 $ | 31/03/2024 |
Posizioni attive di Philip Herman
| Società | Posizione | Inizio |
|---|---|---|
| REPARE THERAPEUTICS INC. | Corporate Officer/Principal | 05/01/2022 |
Precedenti posizioni note di Philip Herman
| Società | Posizione | Fine |
|---|---|---|
| Y-MABS THERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2021 |
| VANDA PHARMACEUTICALS INC. | Sales & Marketing | - |
| DYAX CORP. | Sales & Marketing | - |
Formazione di Philip Herman
| Kellogg School of Management | Masters Business Admin |
| Baldwin Wallace University School of Business | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VANDA PHARMACEUTICALS INC. | Health Technology |
| Y-MABS THERAPEUTICS, INC. | Health Technology |
| REPARE THERAPEUTICS INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
- Borsa valori
- Insiders
- Philip Herman
